Related Experiment Video
Updated: Aug 8, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Tuberculosis and alcoholism. A partial solution through detection
Identifying alcoholism in tuberculosis patients using the brief MAST interview is crucial. Early detection aids in selecting patients for specialized therapies, improving treatment outcomes and preventing therapy failures.
Area of Science:
- Public Health
- Infectious Diseases
- Addiction Medicine
Background:
- Alcoholism and tuberculosis frequently co-occur, leading to higher rates of treatment failure.
- Standard outpatient chemotherapy is often ineffective for patients with co-occurring alcoholism and tuberculosis.
- Effective screening tools are needed to identify alcoholic patients within tuberculosis clinics.
Purpose of the Study:
- To evaluate the effectiveness of the brief Michigan Alcoholism Screening Test (MAST) in identifying alcoholism among tuberculosis patients.
- To determine the prevalence of alcoholism in tuberculosis patient populations.
- To advocate for early identification and specialized treatment for alcoholic tuberculosis patients.
Main Methods:
- The brief MAST interview was administered to patients in public health tuberculosis clinics.
- Patient data was collected and analyzed to determine alcoholism prevalence.
- The feasibility of integrating the screening tool into routine clinic operations was assessed.
Main Results:
- The brief MAST interview effectively identified alcoholic patients in tuberculosis clinics.
- Alcoholism prevalence was found to be 25% in New Orleans and 28% in Birmingham.
- The screening test could be administered without disrupting clinic workflow.
Conclusions:
- The brief MAST interview is a valuable tool for identifying alcoholism in tuberculosis patients.
- Early identification facilitates the selection of patients for specialized therapies.
- Addressing alcoholism concurrently with tuberculosis treatment can improve therapeutic success rates.
More Related Videos
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
10:24Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells
Published on: May 22, 2026
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis